arrow
F

Federica Ganci

ircss regina elena national cancer institute
H指数:22
被引数:1,731

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

miRquad: first-in-class dPCR multiplex TaqMan™ Advanced clinical research assay for microRNA detection in head and neck cancer

miRquad:一种首创的dPCR多重TaqMan™高级临床研究检测试剂盒,用于头颈癌中的microRNA检测

2025-12-200
OAAI
MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma

microRNA介导的PTEN下调作为头颈鳞状细胞癌对PI3Kα抑制剂获得性耐药的新型非遗传机制

2025-07-010
PRE
Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer (vol 12, 32, 2024)
2024-03-260
OAAI
Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer
2024-03-051
OAAI
HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis

HSF-1/miR-145-5p转录轴增强腹腔热灌注化疗对腹膜卵巢癌的疗效

2023-08-193
OAAI
METTL3-dependent MALAT1 delocalization drives c-Myc induction in thymic epithelial tumors
2021-09-1626
OAAI
LINC00174 is a novel prognostic factor in thymic epithelial tumors involved in cell migration and lipid metabolism
2020-11-0728
OAAI
Thymic Epithelial Tumors as a Model of Networking: Development of a Synergistic Strategy for Clinical and Translational Research Purposes

胸腺上皮肿瘤作为网络模型: 为临床和转化研究目的开发协同策略

2020-07-141
OAAI
PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma
2020-06-1536
OAAI